PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ShockWave Medical, Inc. (SWAV)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US82489T1043

CUSIP

82489T104

Sector

Healthcare

IPO Date

Mar 7, 2019

Highlights

Market Cap

$12.57B

EPS (TTM)

$4.25

PE Ratio

78.76

Total Revenue (TTM)

$421.78M

Gross Profit (TTM)

$368.26M

EBITDA (TTM)

$103.71M

Year Range

$165.93 - $334.90

Target Price

$324.27

Short %

5.50%

Short Ratio

2.24

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
SWAV vs. DOCS SWAV vs. MNHYX SWAV vs. MEDP SWAV vs. SITE SWAV vs. COST SWAV vs. VOO SWAV vs. AAPL SWAV vs. SPY SWAV vs. NVDA SWAV vs. IWM
Popular comparisons:
SWAV vs. DOCS SWAV vs. MNHYX SWAV vs. MEDP SWAV vs. SITE SWAV vs. COST SWAV vs. VOO SWAV vs. AAPL SWAV vs. SPY SWAV vs. NVDA SWAV vs. IWM

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ShockWave Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-1.00%-0.50%0.00%Thu 23Fri 24Sat 25May 26Mon 27Tue 28Wed 29Thu 30
0.22%
-1.35%
SWAV (ShockWave Medical, Inc.)
Benchmark (^GSPC)

Returns By Period


SWAV

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y (annualized)

N/A

10Y (annualized)

N/A

^GSPC (Benchmark)

YTD

24.05%

1M

1.08%

6M

11.50%

1Y

30.38%

5Y (annualized)

13.77%

10Y (annualized)

11.13%

Monthly Returns

The table below presents the monthly returns of SWAV, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202418.73%15.30%24.82%1.40%75.67%
2023-8.60%1.23%13.98%33.82%-5.19%3.75%-8.69%-15.43%-9.66%3.60%-15.37%9.17%-7.32%
2022-18.71%22.25%17.00%-27.12%8.65%16.42%10.34%40.74%-6.33%5.42%-13.49%-18.92%15.30%
202111.88%0.62%11.56%25.49%10.06%5.46%-4.07%17.70%-3.89%3.80%-15.66%-1.06%71.93%
2020-1.14%-7.55%-17.34%20.92%9.70%7.63%4.12%28.83%19.29%-9.87%43.19%6.02%136.16%
20199.74%27.31%40.32%-4.52%-14.31%-14.45%-28.48%13.67%15.11%12.16%44.00%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SWAV is 63, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of SWAV is 6363
Combined Rank
The Sharpe Ratio Rank of SWAV is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of SWAV is 6060
Sortino Ratio Rank
The Omega Ratio Rank of SWAV is 6363
Omega Ratio Rank
The Calmar Ratio Rank of SWAV is 6868
Calmar Ratio Rank
The Martin Ratio Rank of SWAV is 5858
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ShockWave Medical, Inc. (SWAV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
SWAV
^GSPC

There is not enough data available to calculate the Sharpe ratio for ShockWave Medical, Inc.. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.

Rolling 12-month Sharpe Ratio0.501.001.502.002.50Thu 23Fri 24Sat 25May 26Mon 27Tue 28Wed 29Thu 30
0.50
2.14
SWAV (ShockWave Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


ShockWave Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-1.50%-1.00%-0.50%0.00%Thu 23Fri 24Sat 25May 26Mon 27Tue 28Wed 29Thu 30
-0.02%
-1.61%
SWAV (ShockWave Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ShockWave Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ShockWave Medical, Inc. was 64.92%, occurring on Mar 20, 2020. Recovery took 115 trading sessions.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-64.92%Jun 11, 2019197Mar 20, 2020115Sep 2, 2020312
-52.07%Nov 5, 2021127May 9, 202263Aug 9, 2022190
-48.16%Aug 26, 2022305Nov 10, 202392Mar 26, 2024397
-34.72%Jan 20, 202133Mar 8, 202131Apr 21, 202164
-21.97%Mar 18, 201918Apr 10, 201910Apr 25, 201928

Volatility

Volatility Chart

The current ShockWave Medical, Inc. volatility is 1.39%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


1.50%2.00%2.50%3.00%Thu 23Fri 24Sat 25May 26Mon 27Tue 28Wed 29Thu 30
1.39%
2.69%
SWAV (ShockWave Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ShockWave Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for ShockWave Medical, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items